Flumexadol
| CERM-1841, 1841-CERM | |
|---|---|
| Molecular structure via molpic based on CDK |
| Physical properties [] | |
|---|---|
| Molecular mass | 231.21 g/mol [1] |
| Predicted LogP | 2 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C11H12F3NO [1] |
| IUPAC name | 2-[3-(trifluoromethyl)phenyl]morpholine [1] |
| SMILES | C1COC(CN1)C2=CC(=CC=C2)C(F)(F)F [1] |
| InChI | InChI=1S/C11H12F3NO/c12-11(13,14)9-3-1-2-8(6-9)10-7-15-4-5-16-10/h1-3,6,10,15H,4-5,7H2 [1] |
| InChIKey | GXPYCYWPUGKQIJ-UHFFFAOYSA-N [1] |
Flumexadol (also known as 2-(3-(Trifluoromethyl)phenyl)morpholine, Flumexadolum, 2-(α,α,α-Trifluoro-m-tolyl)morpholine, Unii-v9783uel0f, Brn 1215543, Tetrahydro-2-(α,α,α-trifluoro-m-tolyl)-1,4-oxazine, 1,4-Oxazine, tetrahydro-2-(α,α,α-trifluoro-m-tolyl)-, Flumexadol, (+-)-, 2-(3-trifluoromethyl)phenyltetrahydro-1,4-oxazine or 862-087-9) is a
Chemistry
Stereochemistry []
Flumexadol is a racemic mixture of the enantiomers.
| Stereoisomerism |
|---|
| Stereoisomer enumberation with rdkit |
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 65774, Flumexadol. Accessed May 12, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/65774